Literature DB >> 21826581

Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage.

M Y Tseng1.   

Abstract

Statins were shown to have neuroprotective effects, with reduced vasospasm and delayed ischemic deficits in statin-treated patients after aneurysmal subarachnoid hemorrhage in two small, randomized, controlled clinical trials published in 2005. This review consolidated data from available published studies evaluating statin treatment for subarachnoid hemorrhage. A literature search was conducted to identify original research studies published through October 2010 testing immediate treatment with a statin in statin-naïve patients following aneurysmal SAH. Six randomized controlled clinical trials and four observational studies were identified. Despite inconsistent results among studies, a meta-analysis of randomized controlled data showed a significant reduction in delayed ischemic deficits with statins. Effect on vasospasm was more difficult to determine, due to differences in definitions used among studies. Interpretations from observational studies were limited by the use of relatively small sample sizes, historical controls, and treatment variability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21826581     DOI: 10.1007/s12028-011-9596-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  13 in total

1.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

Review 2.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.

Authors:  Joshua B Bederson; E Sander Connolly; H Hunt Batjer; Ralph G Dacey; Jacques E Dion; Michael N Diringer; John E Duldner; Robert E Harbaugh; Aman B Patel; Robert H Rosenwasser
Journal:  Stroke       Date:  2009-01-22       Impact factor: 7.914

Review 3.  Statins: a potential therapeutic addition to treatment for aneurysmal subarachnoid hemorrhage?

Authors:  Mohammed Sabri; R Loch Macdonald
Journal:  World Neurosurg       Date:  2010-06       Impact factor: 2.104

4.  Statins may not protect against vasospasm in subarachnoid haemorrhage.

Authors:  Michael Kern; Mark M F Lam; Neville W Knuckey; Christopher R P Lind
Journal:  J Clin Neurosci       Date:  2009-02-23       Impact factor: 1.961

Review 5.  Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  Andreas H Kramer; Jeffrey J Fletcher
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

6.  Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.

Authors:  Mervyn D I Vergouwen; Joost C M Meijers; Ronald B Geskus; Bert A Coert; Janneke Horn; Erik S G Stroes; Tom van der Poll; Marinus Vermeulen; Yvo B W E M Roos
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-20       Impact factor: 6.200

Review 7.  Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.

Authors:  Mervyn D I Vergouwen; Rob J de Haan; Marinus Vermeulen; Yvo B W E M Roos
Journal:  Stroke       Date:  2009-10-29       Impact factor: 7.914

8.  A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage.

Authors:  Sherry H-Y Chou; Eric E Smith; Neeraj Badjatia; Raul G Nogueira; John R Sims; Christopher S Ogilvy; Guy A Rordorf; Cenk Ayata
Journal:  Stroke       Date:  2008-07-24       Impact factor: 7.914

Review 9.  Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study.

Authors:  Matthew J McGirt; Giannina L Garces Ambrossi; Judy Huang; Rafael J Tamargo
Journal:  J Neurosurg       Date:  2009-05       Impact factor: 5.115

10.  Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial.

Authors:  Ming-Yuan Tseng; Marek Czosnyka; Hugh Richards; John D Pickard; Peter J Kirkpatrick
Journal:  Stroke       Date:  2005-08       Impact factor: 7.914

View more
  19 in total

1.  Statins and anti-inflammatory therapies for subarachnoid hemorrhage.

Authors:  Rajat Dhar; Michael Diringer
Journal:  Curr Treat Options Neurol       Date:  2012-04       Impact factor: 3.598

Review 2.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

Review 3.  Delayed neurological deterioration after subarachnoid haemorrhage.

Authors:  R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

4.  Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment.

Authors:  J Marc Simard; E Francois Aldrich; David Schreibman; Robert F James; Adam Polifka; Narlin Beaty
Journal:  J Neurosurg       Date:  2013-09-13       Impact factor: 5.115

5.  Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial.

Authors:  Masato Naraoka; Naoya Matsuda; Norihito Shimamura; Kenichiro Asano; Kenichi Akasaka; Atsuhito Takemura; Seiko Hasegawa; Hiroki Ohkuma
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-01       Impact factor: 6.200

Review 6.  [Aneurysmal subarachnoid hemorrhage].

Authors:  P Kellner; D Stoevesandt; J Soukup; M Bucher; C Raspé
Journal:  Anaesthesist       Date:  2012-09       Impact factor: 1.041

7.  [Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: prevention, diagnostics and therapy].

Authors:  S Wolf; K E Wartenberg
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

Review 8.  Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemia.

Authors:  Christian Burrell; Nicole E Avalon; Jason Siegel; Michael Pizzi; Tumpa Dutta; M Cristine Charlesworth; William D Freeman
Journal:  Expert Rev Neurother       Date:  2016-07-11       Impact factor: 4.618

9.  Statins Improve Clinical Outcome After Non-aneurysmal Subarachnoid Hemorrhage: A Translational Insight From a Systematic Review of Experimental Studies.

Authors:  Sepide Kashefiolasl; Marlies Wagner; Nina Brawanski; Volker Seifert; Stefan Wanderer; Lukas Andereggen; Juergen Konczalla
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

10.  Suppression of the Rho/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit.

Authors:  Masato Naraoka; Akira Munakata; Naoya Matsuda; Norihito Shimamura; Hiroki Ohkuma
Journal:  Transl Stroke Res       Date:  2013-01-29       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.